Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A2A receptor agonists and endotoxin

Under normoxic conditions, macrophages from C57BL mice produce low levels of vascular endothelial growth factor (VEGF). Hypoxia stimulates VEGF expression by ∼500%; interferon-γ (IFN-γ) with endotoxin [lipopolysaccharide (LPS)] also stimulates VEGF expression by ∼50 to 150% in an inducible nitric oxide synthase (iNOS)-dependent manner. Treatment of normoxic macrophages with 5′- N -ethyl-carboxamido-adenosine (NECA), a nonselective adenosine A 2 receptor agonist, or with 2-[ p -(2-carboxyethyl)-phenylethyl amino]-5′- N -ethyl-carboxamido-adenosine (CGS21680), a specific adenosine A 2A receptor agonist, modestly increases VEGF expression, whereas 2-chloro- N 6 -cyclopentyl adenosine (CCPA), an adenosine A 1 agonist, does not. Treatment with LPS (0 to 1000 ng/ml), or with IFN-γ (0 to 300 U/ml), does not affect VEGF expression. In the presence of LPS (EC 50 in vivo in the rat corneal bioassay of angiogenesis. Inhibitors of iNOS do not affect this synergistic induction of VEGF, and macrophages from iNOS−/− mice produce similar levels of VEGF as wild-type mice, indicating that NO does not play a role in this induction. Under hypoxic conditions, VEGF expression is slightly increased by adenosine receptor agonists but adenosine A 2 or A 1 receptor antagonists 3,7-dimethyl-1-propargyl xanthine (DMPX), ZM241385, and 8-cyclopentyl-1,3-dipropylxanthine (DCPCX) do not modulate VEGF expression. VEGF expression is also not reduced in hypoxic macrophages from A 3 −/− and A 2A −/− mice. Thus, VEGF expression by hypoxic macrophages does not seem to depend on endogenously released or exogenous adenosine. VEGF expression is strongly up-regulated by LPS/NECA in macrophages from A 3 −/− but not A 2A −/− mice, confirming the role of adenosine A 2A receptors in this pathway. LPS with NECA strongly up-regulates VEGF expression by macrophages from C 3 H/HeN mice (with intact Tlr4 receptors), but not by macrophages from C 3 H/HeJ mice (with mutated, functionally inactive Tlr4 receptors), implicating signaling through the Tlr4 pathway in this synergistic up-regulation. Finally, Western blot analysis of adenosine A 2A receptor expression indicated that the synergistic interaction of LPS with A 2A receptor agonists does not involve up-regulation of A 2A receptors by LPS. These results indicate that in murine macrophages there is a novel pathway regulating VEGF production, that involves the synergistic interaction of adenosine A 2A receptor agonists through A 2A receptors with LPS through the Tlr4 pathway, resulting in the strong up-regulation of VEGF expression by macrophages in a hypoxia- and NO-independent manner.